Nutrition and the Brain

Clinics in Geriatric Medicine

Volumn 26, Issue 1, 2010, Pages 89-98

  Morley, John E ^a,b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alpha lipoic acid; Brain; Leptin; Lutein; Nutrition; Triglycerides

Indexed keywords

ACETYLCYSTEINE; CHOLECYSTOKININ; GHRELIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEPTIN; THIOCTIC ACID; TRIACYLGLYCEROL;

ALZHEIMER DISEASE; BRAIN; COGNITION; CYANOCOBALAMIN DEFICIENCY; DEMENTIA; DIABETES MELLITUS; DIABETIC NEUROPATHY; ENZYME ACTIVITY; EXERCISE; FEEDING BEHAVIOR; HIPPOCAMPUS; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; MEMORY; MENTAL HEALTH; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATIVE STRESS; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN D DEFICIENCY;

APPETITE REGULATION; COGNITION DISORDERS; DEMENTIA; HUMANS; NUTRITION DISORDERS;

EID: 76749128557     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2009.11.005     Document Type: Review

References (92)

1. Goodwin J.S., Goodwin J.M., and Garry P.J. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 249 (1983) 2917-2921
2. Morley J.E., and Thomas D.R. Cachexia: new advances in the management of wasting diseases. J Am Med Dir Assoc 9 (2008) 205-210
3. Morley J.E. Weight loss in the nursing home. J Am Med Dir Assoc 8 (2007) 201-204
4. Sloane P.D., Ivey J., Helton M., et al. Nutritional issues in long-term care. J Am Med Dir Assoc 9 (2008) 476-485
5. Flaherty J.H., Shay K., Weir C., et al. The development of a mental status vital sign for use across the spectrum of care. J Am Med Dir Assoc 10 (2009) 379-380
6. Flaherty J.H., Rudolph J., Shay K., et al. Delirium is a serious and under-recognized problem: why assessment of mental status should be the sixth vital sign. J Am Med Dir Assoc 8 (2007) 273-275
7. Eeles E., and Rockwood K. Delirium in the long-term care setting: clinical and research challenges. J Am Med Dir Assoc 9 (2008) 157-161
8. Abellan van Kan G., Roland Y.M., Morley J.E., et al. Frailty: toward a clinical definition. J Am Med Dir Assoc 9 (2008) 71-72
9. Abellan van Kan G., Rolland Y., Bergman H., et al. The I.A.N.A. task force on frailty assessment of older people in clinical practice. J Nutr Health Aging 12 (2008) 29-37
10. Lee M., and Chodosh J. Dementia and life expectancy: what do we know?. J Am Med Dir Assoc 10 (2009) 466-471
11. Hogan D.B., Bailey P., Black S., et al. Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia. CMAJ 179 (2008) 1019-1026
12. Erickson K.I., Prakash R.S., Voss M.W., et al. Aerobic fitness is associated with hippocampal volume in elderly humans. Hippocampus 19 (2009) 1030-1039
13. Rolland Y., Abellan va Kan G., and Vellas B. Physical activity and Alzheimer's disease: from prevention to therapeutic perspectives. J Am Med Dir Assoc 9 (2008) 390-405
14. Rolland Y., Pillard F., Klapouszczak A., et al. Exercise program for nursing home residents with Alzheimer's disease: a 1-year randomized, controlled trial. J Am Geriatr Soc 55 (2007) 158-165
15. Morley J.E. The magic of exercise. J Am Med Dir Assoc 9 (2008) 375-377
16. Morley J.E. Managing persons with dementia in the nursing home: high touch trumps high tech. J Am Med Dir Assoc 9 (2008) 139-146
17. Flood J.F., Merbaum M.O., and Morley J.E. The memory enhancing effects of cholecystokinin octapeptide are dependent on an intact stria terminalis. Neurobiol Learn Mem 64 (1995) 139-145
18. Flood J.F., Garland J.S., and Morley J.E. Evidence that cholecystokinin-enhanced retention is mediated by changes in opioid activity in the amygdale. Brain Res 585 (1992) 94-104
19. Flood J.F., Smith G.E., and Morley J.E. Modulation of memory processing by cholecystokinin: dependence on the vagus nerve. Science 236 (1987) 832-834
20. Diano S., Farr S.A., Benoit S.C., et al. Ghrelin controls hippocampal spine synapse density and memory performance. Nat Neurosci 9 (2006) 381-388
21. Morley J.E., Farr S.A., and Flood J.F. Antibody to amyloid beta protein alleviates impaired acquisition, retention, and memory processing in SAMP8 mice. Neurobiol Learn Mem 78 (2002) 125-138
22. Morley J.E. The SAMP8 mouse: a model of Alzheimer disease?. Biogerontology 3 (2002) 57-60
23. Morley J.E., Kumar V.B., Bernardo A.E., et al. Beta-amyloid precursor polypeptide in SAMP8 mice affects learning and memory. Peptides 21 (2000) 1761-1767
24. Morley J.E., Flood J., and Silver A.J. Effects of peripheral hormones on memory and ingestive behaviors. Psychoneuroendocrinology 17 (1992) 391-399
25. Farr S.A., Banks W.A., and Morley J.E. Effects of leptin on memory processing. Peptides 27 (2006) 1420-1425
26. Farr S.A., Yamada K.A., Butterfield D.A., et al. Obesity and hypertriglyceridemia produce cognitive impairment. Endocrinology 149 (2008) 2628-2636
27. Banks W.A., Farr S.A., and Morley J.E. The effects of high fat diets on the blood-brain barrier transport of leptin: failure or adaptation?. Physiol Behav 88 (2006) 244-248
28. Sims R.C., Madhere S., Gordon S., et al. Relationships among blood pressure, triglycerides and verbal learning in African Americans. J Natl Med Assoc 100 (2008) 1193-1198
29. De Frias C.M., Bunce D., Wahlin A., et al. Cholesterol and triglycerides moderate the effect of apolipoprotein E on memory functioning in older adults. J Gerontol B Psychol Sci Soc Sci 62 (2007) P112-P118
30. Mazza A.D., and Morley J.E. Update on diabetes in the elderly and the application of current therapeutics. J Am Med Dir Assoc 8 (2007) 489-492
31. Flood J.F., Mooradian A.D., and Morley J.E. Characteristics of learning and memory in streptozocin-induced diabetes mellitus. Diabetes 39 (1990) 1391-1398
32. Mooradian A.D., Perryman K., Fitten J., et al. Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiologic studies. Arch Intern Med 148 (1988) 2369-2372
33. Meneilly G.S., Cheung E., Tessier D., et al. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. J Gerontol 48 (1993) M117-M121
34. Strachan M.W., Reynolds R.M., Frier B.M., et al. The relationship between type 2 diabetes and dementia. Br Med Bull 88 (2008) 131-146
35. Heo J.H., Lee S.T., Chu K., et al. White matter hyperintensities and cognitive dysfunction in Alzheimer's disease. J Geriatr Psychiatry Neurol 22 (2009) 207-212
36. Rosenthal M.J., Fajardo M., Gilmore S., et al. Hospitalization and mortality of diabetes in older adults. A 3-year prospective study. Diabetes Care 21 (1998) 231-235
37. Morley J.E., and Flood J.F. Psychosocial aspects of diabetes mellitus in older persons. J Am Geriatr Soc 38 (1990) 605-606
38. Tariq S.H., Tumosa N., Chibnall J.T., et al. Comparison of the Saint Louis University mental status examination and the mini-mental state examination for detecting dementia and mild neurocognitive disorder-a pilot study. Am J Geriatr Psychiatry 14 (2006) 900-910
39. Banks W.A., and Morley J.E. Memories are made of this: recent advances in understanding cognitive impairments and dementia. J Gerontol A Biol Sci Med Sci 58 (2003) 314-321
40. Kaufer D.I., Williams C.S., Braaten A.J., et al. Cognitive screening for dementia and mild cognitive impairment in assisted living: comparison of 3 tests. J Am Med Dir Assoc 9 (2008) 586-593
41. de Tullio M.B., Morelli L., and Castano E.M. The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme: a biological perspective. Prion 2 (2008) 51-56
42. Morley J.E., Farr S.A., Banks W.A., et al. A physiological role for amyloid-beta protein: enhancement of learning and memory. J Alzheimers Dis (2009) [Epub ahead of print]
43. Dhamoon M.S., Noble J.M., and Craft S. Intranasal insulin improves cognition and modulates beta-amyloid in early AD. Neurology 72 (2009) 292-293
44. Joshi S., and Morley J.E. Cognitive impairment. Med Clin North Am 90 (2006) 769-787
45. Morley J.E. Should all long-term care residents receive vitamin D?. J Am Med Dir Assoc 8 (2007) 69-70
46. Munir J., Wright R.J., and Carr D.B. A quality improvement study on calcium and vitamin D supplementation in long-term care. J Am Med Dir Assoc 8 2 Suppl 2 (2007) e19-e23
47. Drinka P.J., Krause P.F., Nest L.J., et al. Determinants of vitamin D levels in nursing home residents. J Am Med Dir Assoc 8 (2007) 76-79
48. Hamid Z., Riggs A., Spencer T., et al. Vitamin D deficiency in residents of academic long-term care facilities despite having been prescribed vitamin D. J Am Med Dir Assoc 8 (2007) 71-75
49. Perry III H.M., Horowitz M., Morley J.E., et al. Longitudinal changes in serum 25-hydroxyvitamin D in older people. Metabolism 48 (1999) 1028-1032
50. Dharmarajan T.S. Falls and fractures linked to anemia, delirium osteomalacia, medications, and more: the path to success is strewn with obstacles!. J Am Med Dir Assoc 8 (2007) 549-550
51. Annweiler C., Allali G., Allain P., et al. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol 16 (2009) 1083-1089
52. Lee D.M., Tajar A., Ulubaev A., et al. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J Neurol Neurosurg Psychiatr 80 (2009) 722-729
53. Buell J.S., Scott T.M., Dawson-Hughes B., et al. Vitamin D is associated with cognitive function in elders receiving home health services. J Gerontol A Biol Sci Med Sci 64 (2009) 888-895
54. Morley J.E. Vitamin D redux. J Am Med Dir Assoc 10 (2009) 591-592
55. Sultana R., Perluigi M., and Butterfield D.A. Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis. Acta Neuropathol 118 (2009) 131-150
56. Isaac M.G., Quinn R., and Tabet N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst Rev 3 (2008) CD002854
57. Flood J.F., and Morley J.E. Learning and memory in the SAMP8 mouse. Neurosci Biobehav Rev 22 (1998) 1-20
58. Petursdottir A.L., Farr S.A., Morley J.E., et al. Lipid perioxidation I brain during aging in the senescence-accelerated mouse (SAM). Neurobiol Aging 28 (2007) 1170-1178
59. Poon H.F., Farr S.A., Banks W.A., et al. Proteomic identification of less oxidized brain proteins in aged senescence-accelerated mice following administration of antisense oligonucleotide directed at the Abeta region of amyloid precursor protein. Brain Res Mol Brain Res 138 (2005) 8-16
60. Poon H.F., Joshi G., Sultana R., et al. Antisense directed at the Abeta region of APP decreases brain oxidative markers in aged senescence accelerated mice. Brain Res 1018 (2004) 86-96
61. Poon H.F., Castegna A., Farr S.A., et al. Quantitative proteomics analysis of specific protein expression and oxidative modification in aged senescence-accelerated-prone 8 mice brain. Neuroscience 126 (2004) 915-926
62. Farr S.A., Poon H.F., Dognukol-Ak D., et al. The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice. J Neurochem 84 (2003) 1173-1183
63. Banks W.A., Farr S.A., La Scola M.E., et al. Intravenous human interleukin-1 alpha impairs memory processing in mice: dependence on blood-brain barrier transport into posterior division of the septum. J Pharmacol Exp Ther 299 (2001) 536-541
64. Poon H.F., Farr S.A., Thongboonkerd V., et al. Proteomic analysis of specific brain proteins in aged SAMP8 mice treated with alpha-lipoic acid: implications for aging and age-related neurodegenerative disorders. Neurochem Int 46 (2005) 159-168
65. de Freitas R.M. Lipoic acid increases hippocampal choline acetyltransferase and acetylcholinersterase activites and improvement memory in epileptic rats. Neurochem Res (2009) [Epub ahead of print]
66. Shenk J.C., Liu J., Fischbach K., et al. The effect of acetyl-L-carnitine and R-alpha-lipoic acid treatment in ApoE4 mouse as a model of human Alzheimer's disease. J Neurol Sci 283 1-2 (2009) 199-206
67. Suchy J., Chan A., and Shea T.B. Dietary supplementation with a combination of alpha-lipoic acid, acetyl-L-carnitine, glycerophosphocoline, docosahexaenoic acid, and phosphatidylserine reduces oxidative damage to murine brain and improves cognitive performance. Nutr Res 29 (2009) 70-74
68. Moreira P.I., Harris P.L., Zhu X., et al. Lipoic acid and N-acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. J Alzheimers Dis 12 (2007) 195-206
69. Singh U., and Jialal I. Alpha-lipoic acid supplementation and diabetes. Nutr Rev 66 (2008) 646-657
70. Packer L., Witt E.H., and Tritschler H.J. Alpha-Lipoic acid as a biological antioxidant. Free Radic Biol Med 19 (1995) 227-250
71. Banks W.A., Farr S.A., and Morley J.E. Entry of blood-borne cytokines into the central nervous system: effects on cognitive processes. Neuroimmunomodulation 10 (2002-2003) 319-327
72. Haren M.T., Malmstrom T.K., Miller D.K., et al. Higher C-Reactive protein and soluble tumor necrosis factor receptor levels are associated with poor physical function and disability: a cross-sectional analysis of a cohort of late middle-aged African Americans. J Gerontol A Biol Sci Med Sci (2009) [Epub ahead of print]
73. Hager K., Kenklies M., McAfoose J., et al. Alpha-lipoic acid as a new treatment option for Alzheimer's disease-A 48 months follow-up analysis. J Neural Transm Suppl 72 (2007) 189-193
74. Sauer J., Tabet N., and Howard R. Alpha lipoic acid for dementia. Cochrane Database Syst Rev 1 (2004) CD004244
75. Féart C., Samieri C., Rondeau V., et al. Adherence to a Mediterranean diet, cognitive decline, and risk of dementia. JAMA 302 (2009) 638-648
76. Huang T.L., Zandi P.P., Tucker K.L., et al. Benefits of fatty fish on dementia risk are stronger for those without APOE epsilon4. Neurology 65 (2005) 1409-1414
77. Dangour A.D., Allen E., Elbourne D., et al. Fish consumption and cognitive function among older people in the UK: baseline data from the OPAL study. J Nutr Health Aging 13 (2009) 198-202
78. Morris M.C. The role of nutrition in Alzheimer's disease: epidemiological evidence. Eur J Neurol 16 Suppl 1 (2009) 1-7
79. Petursdottir A.L., Farr S.A., Morley J.E., et al. Effect of dietary n-3 polyunsaturated fatty acids on brain lipid fatty acid composition, learning ability, and memory of senescence-accelerated mouse. J Gerontol A Biol Sci Med Sci 63 (2008) 1153-1160
80. Kumar V.B., Vyas K., Buddhiraju M., et al. Changes in membrane fatty acids and delta-9 desaturase in senescence accelerated (SAMP8) mouse hippocampus with aging. Life Sci 65 (1999) 1657-1662
81. Cherubini A., Andres-Lacueva C., Martin A., et al. Low plasma N-3 fatty acids and dementia in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 62 (2007) 1120-1126
82. Joseph J.A., Shukitt-Hale B., and Willis L.M. Grape juice, berries, and walnuts affect brain aging and behavior. J Nutr 139 (2009) 1813S-1817S
83. Shukitt-Hale B., Lau F.C., Carey A.N., et al. Blueberry polyphenols attenuate kainic acid-induced decrements in cognition and alter inflammatory gene expression in rat hippocampus. Nutr Neurosci 11 (2008) 172-182
84. Lim G.P., Chu T., Yang F., et al. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 21 (2001) 8370-8377
85. Ringman J.M., Frautschy S.A., Cole G.M., et al. A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res 2 (2005) 131-136
86. Ng T.P., Chiam P.C., Lee T., et al. Curry consumption and cognitive function in the elderly. Am J Epidemiol 164 (2006) 898-906
87. Knopman D.S. Mediterranean diet and late-life cognitive impairment: a taste of benefit. JAMA 302 (2009) 686-687
88. Scarmeas N., Stern Y., Mayeux R., et al. Mediterranean diet and mild cognitive impairment. Arch Neurol 66 (2009) 216-225
89. Wurtman R.J., Cansev M., and Ulus I.H. Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phospatides. J Nutr Health Aging 13 (2009) 189-197
90. Wurtman R.J., Cansev M., Sakamoto T., et al. Administration of docosahexaenoic acid, uridine and choline increases levels of synaptic membranes and dendritic spines in rodent brain. World Rev Nutr Diet 99 (2009) 71-96
91. Holguin S., Huang Y., Liu J., et al. Chronic administration of DHA and UMP improves the impaired memory of environmentally improverished rats. Behav Brain Res 191 (2008) 11-16
92. Johnson E.J., McDonald K., Caldarella S.M., et al. Cognitive findings of an exploratory trial of docosahexaenoic acid supplementation in older women. Nutr Neurosci 11 (2008) 75-83